| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |